January 16, 2025

post

Atley Solutions and Nusano in collaboration to accelerate astatine-211 development

Atley Solutions and Nusano today announced a non-exclusive memorandum of understanding (MOU) to co-develop astatine-211 (At-211) solutions for the rapidly emerging applications of the isotope in oncology therapeutics.